Yvonne Wilding

Yvonneは20年以上にわたり、新薬や新規ドラッグデリバリーデバイスの戦略的デザインおよびオペレーションを主導。She has worked on more than 100 successful global pharma regulatory submissions – IND, CTA MAA, NDA, JNDA and PMTA in respiratory, cardiovascular, oncology immunology, and orphan drug indications, including small molecules, orphan drugs and biologicals. Yvonne has extensive experience designing and implementing change, releasing value and driving benefit realization within complex global organisations.